SOS
NVO

Silver Oak Securities’s Novo Nordisk NVO Stock Holding History

Silver Oak Securities’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$619K Sell
12,911
-65
-0.5% -$2.79K 0.04% 408
2026
Q1 		$477K Buy
12,976
+2,120
+20% +$100K 0.03% 452
2025
Q4 		$556K Buy
+10,856
New +$555K 0.04% 428

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Silver Oak Securities's NVO Position: Q2 2026 in Review

Silver Oak Securities reduced its Novo Nordisk (NVO) stake by 0.5% in Q2 2026, selling an estimated $2.79K and leaving 12,911 shares worth $619K. The position accounts for 0.04% of the portfolio, ranked #408.

Silver Oak Securities first reported a position in NVO in Q4 2025 and has held it in 3 quarters since. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Silver Oak Securities held 12,911 shares of Novo Nordisk worth $619K as of Q2 2026.
  • Silver Oak Securities sold 65 Novo Nordisk shares in Q2 2026, an estimated $2.79K.
  • Novo Nordisk made up 0.04% of Silver Oak Securities's portfolio in Q2 2026, its #408 holding.
  • Silver Oak Securities first reported a position in Novo Nordisk in Q4 2025 and has held it in 3 quarters since.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Silver Oak Securities's 13F filing for Q2 2026, filed 7 Aug 2026.